Markets:

Overview

News

Currencies

International

Treasuries

Innate Pharma S.A. - American Depositary Shares (NQ:IPHA)

1.790 +0.050 (+2.90%)

Streaming Delayed Price Updated: 3:36 PM EST, Feb 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Innate Pharma S.A. - American Depositary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Innate Pharma to present adenosine franchise, IPH5201 and IPH5301 at ESMO IO 2022

December 01, 2022

From Innate Pharma SA

Via Business Wire

Innate Pharma Reports Third Quarter Financial Results

November 14, 2022

From Innate Pharma SA

Via Business Wire

Innate Pharma Announces Conference Call and Webcast for Third Quarter 2022 Business Update

November 07, 2022

From Innate Pharma SA

Via Business Wire

Innate Pharma to Present Results From a Preliminary Analysis of the TELLOMAK Phase 2 Trial in Patients With Advanced Sezary Syndrome and ANKET™ Platform at ASH 2022

November 04, 2022

From Innate Pharma SA

Via Business Wire

Innate Pharma to Participate in Upcoming Investor Conferences

November 02, 2022

From Innate Pharma SA

Via Business Wire

Innate Pharma 2023 Financial Calendar

October 20, 2022

From Innate Pharma SA

Via Business Wire

Innate Pharma Presents Data From Ongoing Phase 2 TELLOMAK Trial Demonstrating Clinical Activity of Lacutamab in Advanced Mycosis Fungoides

September 23, 2022

From Innate Pharma SA

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 19, 2022

Via Benzinga

Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday ↗

September 20, 2022

Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

September 19, 2022

We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning and the news behind them!

Via InvestorPlace

Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session ↗

September 19, 2022

Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.

Via Benzinga

Why bluebird bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving Premarket ↗

September 19, 2022

Gainers FOXO Technologies Inc. (NYSE: FOXO) rose 161% to $10.50 in pre-market trading after dipping 52% on Friday.

Via Benzinga

Earnings Scheduled For September 15, 2022 ↗

September 15, 2022

Companies Reporting Before The Bell • Boqii Holding (NYSE:BQ) is estimated to report earnings for its first quarter.

Via Benzinga

Innate Pharma Reports First Half 2022 Financial Results and Business Update

September 15, 2022

From Innate Pharma SA

Via Business Wire

Innate Pharma Announces Conference Call and Webcast for First Half 2022 Business Update

September 08, 2022

From Innate Pharma SA

Via Business Wire

Innate Pharma to Present Lacutamab PTCL Phase 1b Design and ANKET™ Platform at ESMO 2022

September 05, 2022

From Innate Pharma SA

Via Business Wire

Innate Pharma to Participate in Upcoming Investor Conferences

August 23, 2022

From Innate Pharma SA

Via Business Wire

Number of Shares and Voting Rights of Innate Pharma as of August 1, 2022

August 08, 2022

From Innate Pharma SA

Via Business Wire

Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday ↗

August 02, 2022

Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.

Via Benzinga

This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session ↗

August 01, 2022

Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022.

Via Benzinga

Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial ↗

August 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

AstraZeneca Cuts Innate-Partnered Phase 3 Trial In Head & Neck Cancer ↗

August 01, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 01, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

August 01, 2022

Good morning, trader! We're starting off Monday with a breakdown of the biggest pre-market stock movers traders will want to watch!

Via InvestorPlace

Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket ↗

August 01, 2022

Gainers MAIA Biotechnology, Inc. (NASDAQ: MAIA) rose 37.9% to $8.00 in pre-market trading after jumping 30% on Friday. The company agreed to initially offer 2.00 million shares to the public at a $5.00...

Via Benzinga

Innate Pharma Provides Update on AstraZeneca-Sponsored INTERLINK-1 Phase 3 Study

August 01, 2022

From Innate Pharma SA

Via Business Wire

Innate Pharma to Participate in Upcoming Investor Conference

July 28, 2022

From Innate Pharma SA

Via Business Wire

Second Innate Pharma NK Cell Engager Selected by Sanofi as Drug Candidate for Development

July 21, 2022

From Innate Pharma SA

Via Business Wire

Innate Pharma to Participate in Upcoming Investor Conference

June 23, 2022

From Innate Pharma SA

Via Business Wire

67 Biggest Movers From Yesterday ↗

June 22, 2022

Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Innate Pharma S.A. - American Depositary Shares (NQ:IPHA)

All News about Innate Pharma S.A. - American Depositary Shares

Starting at $3.75/week.

Subscribe Today